Lynette Herscha's most recent trade in Solid Biosciences Inc was a trade of 16,000 Restricted Stock Units done . Disclosure was reported to the exchange on July 27, 2020.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Solid Biosciences Inc | Lynette Herscha | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jul 2020 | 16,000 | 16,000 | - | - | Restricted Stock Units | |
Solid Biosciences Inc | Lynette Herscha | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jul 2020 | 16,000 | 166,000 (0%) | 0% | - | Common Stock | |
Solid Biosciences Inc | Lynette Herscha | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 2.42 per share. | 27 Jul 2020 | 5,141 | 160,859 (0%) | 0% | 2.4 | 12,438 | Common Stock |
Solid Biosciences Inc | Lynette Herscha | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 75,000 | 150,000 (0%) | 0% | 0 | Common Stock |